Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis

Background/AimsPatients with ulcerative colitis (UC) are at high risk for cytomegalovirus (CMV) reactivation. The usefulness of the CMV antigenemia assay in active UC patients has rarely been studied. We assessed whether the assay detects CMV colitis and predicts clinical outcomes in patients with U...

Full description

Bibliographic Details
Main Authors: Jaeyoung Chun, Changhyun Lee, Ji-eun Kwon, Sung Wook Hwang, Sang Gyun Kim, Joo Sung Kim, Hyun Chae Jung, Jong Pil Im
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2015-01-01
Series:Intestinal Research
Subjects:
Online Access:http://www.irjournal.org/upload/pdf/ir-13-50.pdf
_version_ 1818891936741720064
author Jaeyoung Chun
Changhyun Lee
Ji-eun Kwon
Sung Wook Hwang
Sang Gyun Kim
Joo Sung Kim
Hyun Chae Jung
Jong Pil Im
author_facet Jaeyoung Chun
Changhyun Lee
Ji-eun Kwon
Sung Wook Hwang
Sang Gyun Kim
Joo Sung Kim
Hyun Chae Jung
Jong Pil Im
author_sort Jaeyoung Chun
collection DOAJ
description Background/AimsPatients with ulcerative colitis (UC) are at high risk for cytomegalovirus (CMV) reactivation. The usefulness of the CMV antigenemia assay in active UC patients has rarely been studied. We assessed whether the assay detects CMV colitis and predicts clinical outcomes in patients with UC.MethodsWe retrospectively reviewed the medical records of patients hospitalized for moderate-to-severe UC from 2003 to 2012. Positive CMV antigenemia was defined as ≥1 pp65-positive cell per 2×105 polymorphonuclear neutrophils. CMV colitis was defined as the presence of inclusion bodies and/or positive immunohistochemistry in the colonic mucosa. The primary outcome was steroid refractoriness, defined as the absence of clinical improvement after intravenous high-dose steroid administration.ResultsA total of 43 patients were enrolled. CMV antigenemia was detected in 12 (27.9%) patients. Positive CMV antigenemia was significantly associated with CMV colitis (P =0.001). The sensitivity and specificity of positive CMV antigenemia for diagnosing CMV colitis were 66.7% and 87.1%, respectively. Steroid refractoriness was found in 11 of 12 (91.7%) and 12 of 31 (38.7%) patients with positive and negative CMV antigenemia, respectively (P =0.002). The independent predictors for steroid refractoriness were positive CMV antigenemia (adjusted odds ratio [OR], 7.73; 95% confidence interval [CI], 1.22-49.19; P =0.030) and a shorter duration from the diagnosis of UC (adjusted OR, 0.99; 95% CI, 0.98-0.99; P =0.025).ConclusionsThe CMV antigenemia assay shows low sensitivity but high specificity for detecting CMV colitis and may predict steroid-refractory UC. Early rescue therapy might be considered in UC patients positive for CMV antigenemia.
first_indexed 2024-12-19T17:48:44Z
format Article
id doaj.art-2ce94d9678474a729c744560233827a9
institution Directory Open Access Journal
issn 1598-9100
2288-1956
language English
last_indexed 2024-12-19T17:48:44Z
publishDate 2015-01-01
publisher Korean Association for the Study of Intestinal Diseases
record_format Article
series Intestinal Research
spelling doaj.art-2ce94d9678474a729c744560233827a92022-12-21T20:11:58ZengKorean Association for the Study of Intestinal DiseasesIntestinal Research1598-91002288-19562015-01-01131505910.5217/ir.2015.13.1.50123Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative ColitisJaeyoung Chun0Changhyun Lee1Ji-eun Kwon2Sung Wook Hwang3Sang Gyun Kim4Joo Sung Kim5Hyun Chae Jung6Jong Pil Im7Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.Department of Internal Medicine and Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea.Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.Background/AimsPatients with ulcerative colitis (UC) are at high risk for cytomegalovirus (CMV) reactivation. The usefulness of the CMV antigenemia assay in active UC patients has rarely been studied. We assessed whether the assay detects CMV colitis and predicts clinical outcomes in patients with UC.MethodsWe retrospectively reviewed the medical records of patients hospitalized for moderate-to-severe UC from 2003 to 2012. Positive CMV antigenemia was defined as ≥1 pp65-positive cell per 2×105 polymorphonuclear neutrophils. CMV colitis was defined as the presence of inclusion bodies and/or positive immunohistochemistry in the colonic mucosa. The primary outcome was steroid refractoriness, defined as the absence of clinical improvement after intravenous high-dose steroid administration.ResultsA total of 43 patients were enrolled. CMV antigenemia was detected in 12 (27.9%) patients. Positive CMV antigenemia was significantly associated with CMV colitis (P =0.001). The sensitivity and specificity of positive CMV antigenemia for diagnosing CMV colitis were 66.7% and 87.1%, respectively. Steroid refractoriness was found in 11 of 12 (91.7%) and 12 of 31 (38.7%) patients with positive and negative CMV antigenemia, respectively (P =0.002). The independent predictors for steroid refractoriness were positive CMV antigenemia (adjusted odds ratio [OR], 7.73; 95% confidence interval [CI], 1.22-49.19; P =0.030) and a shorter duration from the diagnosis of UC (adjusted OR, 0.99; 95% CI, 0.98-0.99; P =0.025).ConclusionsThe CMV antigenemia assay shows low sensitivity but high specificity for detecting CMV colitis and may predict steroid-refractory UC. Early rescue therapy might be considered in UC patients positive for CMV antigenemia.http://www.irjournal.org/upload/pdf/ir-13-50.pdfColitis, UlcerativeCytomegalovirusAntigensSteroidsTreatment failure
spellingShingle Jaeyoung Chun
Changhyun Lee
Ji-eun Kwon
Sung Wook Hwang
Sang Gyun Kim
Joo Sung Kim
Hyun Chae Jung
Jong Pil Im
Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis
Intestinal Research
Colitis, Ulcerative
Cytomegalovirus
Antigens
Steroids
Treatment failure
title Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis
title_full Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis
title_fullStr Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis
title_full_unstemmed Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis
title_short Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis
title_sort usefulness of the cytomegalovirus antigenemia assay in patients with ulcerative colitis
topic Colitis, Ulcerative
Cytomegalovirus
Antigens
Steroids
Treatment failure
url http://www.irjournal.org/upload/pdf/ir-13-50.pdf
work_keys_str_mv AT jaeyoungchun usefulnessofthecytomegalovirusantigenemiaassayinpatientswithulcerativecolitis
AT changhyunlee usefulnessofthecytomegalovirusantigenemiaassayinpatientswithulcerativecolitis
AT jieunkwon usefulnessofthecytomegalovirusantigenemiaassayinpatientswithulcerativecolitis
AT sungwookhwang usefulnessofthecytomegalovirusantigenemiaassayinpatientswithulcerativecolitis
AT sanggyunkim usefulnessofthecytomegalovirusantigenemiaassayinpatientswithulcerativecolitis
AT joosungkim usefulnessofthecytomegalovirusantigenemiaassayinpatientswithulcerativecolitis
AT hyunchaejung usefulnessofthecytomegalovirusantigenemiaassayinpatientswithulcerativecolitis
AT jongpilim usefulnessofthecytomegalovirusantigenemiaassayinpatientswithulcerativecolitis